Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	21.62	8.71	16.9	22.64	45.04
Cash & Short-Term Investments	21.62	8.71	16.9	22.64	45.04
Cash Growth	148.09%	-48.45%	-25.32%	-49.75%	12.67%
Other Receivables	-	-	-	2.5	3.66
Total Trade Receivables	-	-	-	2.5	3.66
Other Current Assets	1.46	1.95	2.16	2.32	3.86
Total Current Assets	23.08	10.66	19.07	27.45	52.57
Net Property, Plant & Equipment	4.11	4.93	5.78	6.77	3.96
Other Long-Term Assets	-	-	-	-	0.07
Total Assets	27.19	15.59	24.84	34.22	56.6
Accounts Payable	0.88	1.24	3.98	3.5	3.46
Accrued Expenses	4.31	4.2	2.1	2.11	2.08
Current Portion of Long-Term Debt	-	-	-	2	11.67
Current Portion of Leases	0.87	0.77	-	-	-
Other Current Liabilities	-	-	1.14	1.1	17.55
Total Current Liabilities	6.05	6.21	7.22	8.71	34.76
Long-Term Debt	-	-	-	1.46	3.71
Long-Term Leases	3.76	4.63	5.4	6.08	1.34
Other Long-Term Liabilities	-	-	-	-	15.58
Total Long-Term Liabilities	3.76	4.63	5.4	7.54	20.63
Total Liabilities	9.81	10.84	12.62	16.24	55.39
Common Stock	0.11	0.08	0.06	0.05	0.05
Additional Paid-in Capital	292.38	252.25	235.61	223.96	215.23
Retained Earnings	-275.12	-247.58	-223.45	-206.04	-214.06
Shareholders' Equity	17.38	4.76	12.22	17.97	1.22
Total Liabilities & Equity	27.19	15.59	24.84	34.22	56.6
Total Debt	4.63	5.4	5.4	9.54	16.72
Net Cash (Debt)	16.99	3.32	11.51	13.1	28.33
Net Cash Growth	412.21%	-71.17%	-12.16%	-53.76%	125.46%
Net Cash Per Share	53.84	4324.64	1321602.24	1504561.51	3541644.69
Book Value	17.38	4.76	12.22	17.97	1.22
Book Value Per Share	55.08	6199.48	1403606.58	2064350.28	152022.31
Tangible Book Value	17.38	4.76	12.22	17.97	1.22
Tangible Book Value Per Share	55.08	6199.48	1403606.58	2064350.28	152022.31

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q